.jpg)
Wolters Kluwer Health announced the beta launch of the AI Article Summary feature on its Ovid platform on August 27, 2025, designed to streamline medical research by providing instant, trustworthy summaries of peer-reviewed literature. This generative AI tool enhances workflows for healthcare professionals, researchers, and students, addressing the challenges of managing the growing volume of research publications.
Launch: AI Article Summary beta feature introduced on Ovid platform, August 27, 2025.
Functionality: Provides concise, plain-language summaries of peer-reviewed articles from LWW proprietary journals.
Benefits: Saves time, enhances clinical decision-making, and supports evidence-based practices.
Key Quote: “The concise, plain-language snapshot helps users quickly evaluate and understand articles with confidence,” said Rafael Sidi, SVP & General Manager, Wolters Kluwer Health.
Impact: Addresses the 30% annual increase in medical research publications, reducing manual curation time.
Source: Business Wire, August 27, 2025.
The Ovid AI Article Summary tool uses generative AI to deliver structured, consistent summaries that highlight tactical, clinically relevant insights. Integrated directly into the Ovid platform, it eliminates the need to navigate external tools, streamlining research workflows. “Ovid’s AI Article Summary translates intricate research into clear and actionable insights,” said Thomas C. Kingsley, MD, MPH, MS, Assistant Professor at UCLA’s David Geffen School of Medicine.
Instant Summaries: Distills lengthy papers into concise, plain-language synopses.
Research-Centric Design: Aligns with clinician and researcher workflows, focusing on critical findings and methodologies.
Consistency: Uniform summary structure across journals for faster information processing.
Reliability: Built with specialized prompt engineering for accurate, clinically pertinent outputs.
The feature is currently available in beta on select Lippincott (LWW) journals, with plans for broader rollout based on user feedback.
With over 35,000 new medical research articles published monthly, manual curation is increasingly unsustainable. The Ovid AI Article Summary tool reduces research time by up to 50%, enabling clinicians and researchers to stay current with evidence-based insights while balancing patient care and administrative demands. “This is a key step in translating the rapid rate of scientific progress to improvements in clinical care delivery,” Kingsley added.
The tool supports Wolters Kluwer’s broader mission to enhance healthcare outcomes, serving customers in 180+ countries. As AI adoption in healthcare grows (projected 40% CAGR through 2027), Ovid’s integration positions Wolters Kluwer as a leader in research efficiency.
Wolters Kluwer reported €5.9 billion in 2024 revenues, with its Health division driving innovation through tools like Ovid and UpToDate. The AI Article Summary feature complements other offerings, such as Ovid Guidelines AI, which streamlines clinical guideline development. Early user feedback describes the tool as an “essential triage tool” for reducing cognitive load in busy clinical settings.
Wolters Kluwer is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services.
TechIntelPro empowers B2B technology decision-makers with the latest industry trends, deep insights, leadership perspectives and actionable intelligence to drive both organizational and professional milestones—and thrive on the tech pulse.